Cats are not small dogs, pharmacologically speaking. That phrase gets repeated in veterinary medicine for good reason — and it's the single most important thing to understand before applying anything written about dogs to a cat.
Notice a theme? A lot of the momentum behind animal-peptide interest is spilling over from human research. If that side of the story is what actually brought you here, PeptideReport.ai is our sister site covering peptide research for people — register there and get The Peptide Bridge audiobook free, a $29.99 value, delivered to your inbox right away.
Visit PeptideReport.ai + get the free book →Domestic cats have a documented deficiency in glucuronidation, one of the liver's major pathways for clearing many drugs and compounds from the body. The gene for one key enzyme in that pathway, UGT1A6, is a non-functional pseudogene in cats — a genetic quirk shared across the cat family and well established in veterinary pharmacology literature, most famously explaining why cats cannot safely process acetaminophen the way dogs and humans can. This doesn't mean every peptide behaves the way acetaminophen does — it's a different compound class entirely — but it's a concrete example of why feline drug handling can't be assumed from canine or human data, and why "processes differently" isn't a vague caution, it's a documented biochemical fact.
Across the compounds covered on our research index, cat-specific studies are consistently the rarest of the three companion species — rarer than dogs, and often rarer than horses. Most of what exists for cats is extrapolation from other species, not feline-specific data. That's not a Furry Peptides framing choice; it's a description of the actual state of the published literature.
The instinct to scale a dog's information down for a cat by size alone skips over the metabolic difference above entirely. A compound's clearance pathway matters as much as body weight — sometimes more. This is precisely the kind of judgment that requires a licensed veterinarian evaluating your specific cat, not a size-based conversion from information written about a different species.
Because feline data is thinner and feline metabolism has documented quirks, it's worth being explicit with your vet that you're asking about a cat specifically, not assuming information about dogs applies. Our talking to your vet guide covers how to have that conversation productively.
For how feline metabolic differences fit into the bigger picture across species, see peptide research in dogs for the contrast, or the research index for the full compound-by-compound view.
Understanding the research is step one. The real next step is a conversation with a licensed veterinarian who can tell you where your pet's situation actually falls within it.
Talking to Your VetFree bonus: register on PeptideReport.ai today and The Peptide Bridge audiobook — a $29.99 value — is yours free, delivered to your inbox right away.